The Revlar Labs approach to infectious disease diagnostics stands to disrupt the commercial and laboratory markets. Diagnostic efforts include Covid-targeted assays using patented biosensors in vitro, alongside on-site and Point of Care diagnostic solutions. Bypass the challenges associated with typical PCR and rapid antigen tests for COVID. Revlar Labs has designed a better diagnostic solution offering speed, simplicity and sensitivity with the ability for labs to scale accurate, rapid-results tests. CLIA LAB solutions including Hinged Peptid molecular nanoswitches Covid-targeted assay development High-Throughput Lab (HTL) kits ON-SITE COVID SOLUTIONS for Point of Care providers Venues Employers School Campuses CONTACT Tony@Revlarlabs.com